These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15312879

  • 1. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):904-13. PubMed ID: 15312879
    [Abstract] [Full Text] [Related]

  • 2. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M, Ohmori K, Obayashi A, Ishihara Y, Yoshida J, Noma T, Yukiiri K, Kosaka H, Kohno M.
    Hypertens Res; 2009 Jul 18; 32(7):617-24. PubMed ID: 19461650
    [Abstract] [Full Text] [Related]

  • 3. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK, Zhao ZS, Lee YJ, Lee KE, Kang SM, Choi D, Lim SK, Chung N, Lee HC, Cha BS.
    Diabetes Metab Res Rev; 2003 Jul 18; 19(6):487-93. PubMed ID: 14648808
    [Abstract] [Full Text] [Related]

  • 4. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S, Ohno Y, Aoki N.
    Metabolism; 2007 Oct 18; 56(10):1326-33. PubMed ID: 17884440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
    Chen Y, Ohmori K, Mizukawa M, Yoshida J, Zeng Y, Zhang L, Shinomiya K, Kosaka H, Kohno M.
    Circ J; 2007 Jan 18; 71(1):144-52. PubMed ID: 17186993
    [Abstract] [Full Text] [Related]

  • 7. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N, Noma T, Ohyama H, Takahashi T, Kohno M.
    Atherosclerosis; 2002 May 18; 162(1):69-76. PubMed ID: 11947899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
    Jesmin S, Sakuma I, Hattori Y, Fujii S, Kitabatake A.
    Diabetologia; 2002 Mar 18; 45(3):402-15. PubMed ID: 11914746
    [Abstract] [Full Text] [Related]

  • 10. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
    Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Hyodo N, Suzuki S, Miura S.
    Nephrol Dial Transplant; 2005 Aug 18; 20(8):1573-81. PubMed ID: 15905195
    [Abstract] [Full Text] [Related]

  • 11. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats.
    Yoshikawa H, Kihara Y, Taguchi M, Yamaguchi T, Nakamura H, Otsuki M.
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar 18; 282(3):G549-58. PubMed ID: 11842006
    [Abstract] [Full Text] [Related]

  • 12. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakagawa T, Goto H, Hussein G, Hikiami H, Shibahara N, Shimada Y.
    Diabetes Res Clin Pract; 2008 Apr 18; 80(1):40-7. PubMed ID: 18242756
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):316-24. PubMed ID: 18501344
    [Abstract] [Full Text] [Related]

  • 14. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
    Fujita A, Sasaki H, Doi A, Okamoto K, Matsuno S, Furuta H, Nishi M, Nakao T, Tsuno T, Taniguchi H, Nanjo K.
    Diabetes Res Clin Pract; 2008 Jan 07; 79(1):11-7. PubMed ID: 17897750
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T, Kobayashi T, Kamata K.
    Eur J Pharmacol; 2006 May 24; 538(1-3):132-40. PubMed ID: 16678154
    [Abstract] [Full Text] [Related]

  • 16. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T, Tomoda F, Kinuno H, Inoue H, Takata M.
    Acta Physiol Scand; 2005 May 24; 184(1):73-81. PubMed ID: 15847646
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 24; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E, Maekawa K, Tanimoto T, Fujisawa S, Akagi Y.
    Exp Eye Res; 2001 Sep 24; 73(3):375-81. PubMed ID: 11520112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.